DYN vs HSIC · $1.19B cap vs P/E 24, rev $6.83B
Dyne Therapeutics Inc (DYN) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
DYN does not have a complete income-statement cache yet.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
DYN currently screens at market cap $1.19B. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the DYN and HSIC stock pages for the full models.
Not investment advice.